Issue 46, 2022

Total syntheses of Ganoderma-derived meroterpenoids, (−)-oregonensin A, (−)-chizhine E, (−)-applanatumol U, and (−)-ent-fornicin A

Abstract

In this study, we report the total syntheses of Ganoderma-derived meroterpenoids, (−)-oregonensin A, (−)-chizhine E, (−)-applanatumol U, and (−)-ent-fornicin A. The 3-alkyl-5-aryl-γ-butenolide skeleton, a common motif of these meroterpenoids, was constructed through the enantioselective reductive lactonization of the γ-keto ester, alkylation, and sulfoxide-β-syn-elimination. This flexible approach enabled enantioselective access to these meroterpenoids with the longest linear sequence of 6–8 steps, and in 21–36% overall yield, respectively.

Graphical abstract: Total syntheses of Ganoderma-derived meroterpenoids, (−)-oregonensin A, (−)-chizhine E, (−)-applanatumol U, and (−)-ent-fornicin A

Supplementary files

Article information

Article type
Paper
Submitted
08 Oct 2022
Accepted
08 Nov 2022
First published
09 Nov 2022

Org. Biomol. Chem., 2022,20, 9138-9141

Total syntheses of Ganoderma-derived meroterpenoids, (−)-oregonensin A, (−)-chizhine E, (−)-applanatumol U, and (−)-ent-fornicin A

K. Hori, S. Kamo and K. Sugita, Org. Biomol. Chem., 2022, 20, 9138 DOI: 10.1039/D2OB01839J

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements